Rendo V

Loss of heterozygosity of CYP2D6 enhances the sensitivity of hepatocellular carcinomas to talazoparib.

Zhang X, Rameika N, Zhong L, ..., Globisch D, Sjöblom T

EBioMedicine 109 (-) 105368 [2024-11-00; online 2024-10-04]

Daniel Globisch SciLifeLab Fellow

COMPARISON OF HIGH-THROUGHPUT SINGLE-CELL RNA-SEQ METHODS FOR EX VIVO DRUG SCREENING

Gezelius H, Enblad AP, Lundmark A, ..., Andersson C, Nordlund J

- - (-) - [2023-10-01; online 2023-10-01]

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine N-Acetyltransferase NAT2.

Conway LP, Rendo V, Correia MSP, ..., Sjöblom T, Globisch D

Angew. Chem. Int. Ed. Engl. 59 (34) 14342-14346 [2020-08-17; online 2020-07-08]

Daniel Globisch SciLifeLab Fellow

Unexpected Acetylation of Endogenous Aliphatic Amines by Arylamine ‐Acetyltransferase NAT2

Conway LP, Rendo V, Correia MSP, ..., Sjöblom T, Globisch D

Angewandte Chemie 132 (34) 14448-14452 [2020-08-17; online 2020-07-08]

Targeting tumor vulnerabilities associated with loss of heterozygosity.

Rendo V, Stoimenov I, Sjöblom T

Mol Cell Oncol 7 (4) 1759390 [2020-05-13; online 2020-05-13]